Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK.
Aysegül AksanIan L P BealesGarth BaxterAntonio Ramirez de ArellanoSimona GavataWilliam J ValentineBarnaby HuntPublished in: ClinicoEconomics and outcomes research : CEOR (2021)
FCM is likely to be the least costly and most effective IV iron therapy in the UK setting. Compared with oral iron, healthcare payers must decide whether the superior treatment efficacy of FCM is worth the additional cost.